Ligand validation:6MWB

PX4: 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE

PX4 is a Ligand Of Interest in 6MWB designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6MWB_PX4_B_2301	48%	41%	0.186	0.929	1.18	1.13	3	3	1	0	100%	1
6MWB_PX4_B_2303	20%	42%	0.239	0.863	1.14	1.13	2	2	0	0	87%	0.8696
6MWB_PX4_B_2302	5%	41%	0.353	0.777	1.21	1.09	3	2	2	0	93%	0.9348
6MWB_PX4_B_2304	3%	38%	0.352	0.738	1.23	1.18	2	2	2	0	63%	0.6304
8DJ0_PX4_A_1301	65%	83%	0.148	0.949	0.31	0.46	-	-	2	0	100%	1
6MWD_PX4_B_2301	58%	44%	0.165	0.945	1.03	1.15	4	3	1	0	100%	1
6MWA_PX4_B_2301	55%	41%	0.149	0.944	1.09	1.21	4	4	4	0	85%	0.8478
8DJ1_PX4_A_1301	54%	89%	0.18	0.954	0.28	0.36	-	-	1	0	96%	0.9565
6MWG_PX4_B_2301	53%	42%	0.161	0.939	1.08	1.17	4	2	2	0	91%	0.913
8DIV_PX4_A_1302	50%	72%	0.182	0.934	0.4	0.69	-	3	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.